Michael J Griffiths Selected Research

Michael J Griffiths Research Topics

Disease

11	Infections 01/2023 - 02/2008
4	Encephalitis (Encephalitis, Rasmussen) 01/2023 - 09/2012
4	Hydrocephalus (Hydrocephaly) 01/2023 - 01/2014
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2019 - 08/2015
4	Malaria 02/2009 - 02/2008
3	COVID-19 11/2022 - 01/2021
3	Dengue (Dengue Fever) 11/2021 - 01/2018
2	Zika Virus Infection 11/2021 - 01/2021
2	Guillain-Barre Syndrome 01/2021 - 10/2020
2	Viral Meningitis 01/2018 - 04/2017
1	Fever (Fevers) 01/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Exanthema (Rash) 01/2023
1	Autoimmune Diseases of the Nervous System 01/2023
1	Dyskinesias (Dyskinesia) 01/2023
1	Human Influenza (Influenza) 11/2022
1	Brain Injuries (Brain Injury) 11/2022
1	Viremia 11/2021
1	COVID-19 related pediatric multisystem inflammatory disease 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Arbovirus Infections 01/2021
1	Trisomy (Trisomies) 12/2019
1	Aneuploidy (Aneuploid) 12/2019
1	Neurologic Manifestations (Neurological Manifestations) 01/2018
1	Failure to Thrive 01/2018
1	Lethargy 01/2018
1	Meningeal Tuberculosis (Tuberculous Meningitis) 01/2017
1	Coma (Comas) 01/2016
1	Meningitis 09/2012
1	acute flaccid myelitis 09/2012
1	Anemia 02/2008
1	Falciparum Malaria (Plasmodium falciparum Malaria) 02/2008
1	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2007
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2007
1	Leukemia 12/2007

Drug/Important Bio-Agent (IBA)

4	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2014
4	SilverIBA 01/2023 - 01/2014
4	CytokinesIBA 11/2022 - 09/2012
3	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2020
3	Immunoglobulin M (IgM)IBA 11/2021 - 01/2018
3	Rifampin (Rifampicin)FDA LinkGeneric 01/2020 - 01/2014
3	Clindamycin (Cleocin)FDA LinkGeneric 01/2020 - 01/2014
2	SodiumIBA 01/2023 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
2	Immunoglobulin G (IgG)IBA 11/2021 - 01/2021
2	EnzymesIBA 11/2021 - 02/2008
2	ChemokinesIBA 01/2016 - 09/2012
1	Glial Fibrillary Acidic ProteinIBA 11/2022
1	AutoantibodiesIBA 11/2022
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2022
1	ProteomeIBA 01/2022
1	Blood Proteins (Serum Proteins)IBA 01/2022
1	ORALIT (ORS)IBA 01/2022
1	AntigensIBA 11/2021
1	ImmunosorbentsIBA 11/2021
1	GlycolipidsIBA 01/2021
1	IV(4)-galactosyl-N-acetylganglioside GD1aIBA 01/2021
1	Viral RNAIBA 10/2020
1	AntibodiesIBA 10/2020
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 12/2019
1	NucleophosminIBA 12/2019
1	Cell-Free Nucleic AcidsIBA 12/2019
1	dichlorobis(azomycin)platinum IIIBA 12/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	Antiviral Agents (Antivirals)IBA 01/2018
1	Acyclovir (Aciclovir)FDA LinkGeneric 04/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Interleukin-1 (Interleukin 1)IBA 01/2016
1	Minocycline (Cyclops)FDA LinkGeneric 01/2016
1	Serum AlbuminIBA 01/2016
1	Interleukin-10 (Interleukin 10)IBA 01/2016
1	Mitochondrial DNA (mtDNA)IBA 01/2016
1	ChromatinIBA 08/2015
1	SiliconesIBA 01/2014
1	InterleukinsIBA 09/2012
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2012
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 09/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2009
1	Lymphotoxin-alpha (Lymphotoxin)IBA 02/2009
1	Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA 01/2009
1	GTP-Binding Protein alpha SubunitsIBA 12/2008
1	ABO Blood-Group SystemIBA 02/2008
1	GlycosyltransferasesIBA 02/2008
1	Blood Group Antigens (Blood Groups)IBA 02/2008
1	P-2 (P 2)IBA 02/2008
1	Imatinib Mesylate (Gleevec)FDA Link 12/2007

Therapy/Procedure

4	Ventriculoperitoneal Shunt 01/2023 - 01/2014
3	Length of Stay 10/2020 - 01/2018
3	Neurosurgical Procedures 01/2020 - 01/2014
2	Catheters 01/2023 - 01/2014
2	Therapeutics 01/2023 - 12/2007
2	Critical Care (Surgical Intensive Care) 01/2021 - 10/2020
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Transplantation 12/2007
1	Immunotherapy 12/2007
1	Salvage Therapy 12/2007